Showing results (31-40 of 66) with videos related to

Sort By:
Pageof 7
Gut|November 17, 2016
Palbociclib (PD-0332991), a selective CDK4/6 inhibitor, restricts tumour growth in preclinical models of hepatocellular carcinomaJulien Bollard, Verónica Miguela, Marina Ruiz de Galarreta, et al.
Journal of Hepatology|January 28, 2017
Mixed hepatocellular cholangiocarcinoma tumors: Cholangiolocellular carcinoma is a distinct molecular entityAgrin Moeini, Daniela Sia, Zhongyang Zhang, et al.
Gut|December 15, 2015
Tumour initiating cells and IGF/FGF signalling contribute to sorafenib resistance in hepatocellular carcinomaVictoria Tovar, Helena Cornella, Agrin Moeini, et al.
Oncogene|October 24, 2020
Mutations in circulating tumor DNA predict primary resistance to systemic therapies in advanced hepatocellular carcinomaJohann von Felden, Amanda J Craig, Teresa Garcia-Lezana, et al.
Journal of Hepatology|June 28, 2011
Gene-expression signature of vascular invasion in hepatocellular carcinomaBeatriz Mínguez, Yujin Hoshida, Augusto Villanueva, et al.
Gastroenterology|February 16, 2011
Combining clinical, pathology, and gene expression data to predict recurrence of hepatocellular carcinomaAugusto Villanueva, Yujin Hoshida, Carlo Battiston, et al.
Journal of Hepatology|August 28, 2017
Trunk mutational events present minimal intra- and inter-tumoral heterogeneity in hepatocellular carcinomaSara Torrecilla, Daniela Sia, Andrew N Harrington, et al.
Gastroenterology|June 19, 2017
Identification of an Immune-specific Class of Hepatocellular Carcinoma, Based on Molecular FeaturesDaniela Sia, Yang Jiao, Iris Martinez-Quetglas, et al.
Oncogene|April 10, 2018
A pilot study of ultra-deep targeted sequencing of plasma DNA identifies driver mutations in hepatocellular carcinomaIsmail Labgaa, Carlos Villacorta-Martin, Delia D'Avola, et al.
Pageof 7